Oruka Therapeutics, Inc. Debt Securities, Available-for-sale
Oruka Therapeutics, Inc. (ORKA) had Debt Securities, Available-for-sale of $1.12 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-10
- 2026-06-30: Debt Securities, Available-for-sale $1.12B.
- 2026-03-31: Debt Securities, Available-for-sale $491.85M.
- 2025-12-31: Debt Securities, Available-for-sale $477.40M.
- 2025-09-30: Debt Securities, Available-for-sale $498.66M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $1.12B 10-Q · filed 2026-08-10 |
| 2026-03-31 | $491.85M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $477.40M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $498.66M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $349.35M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $368.83M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $384.32M 10-K · filed 2026-03-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-01 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-18 |
| 2023-06-30 | $0.00 10-Q · filed 2023-07-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-24 |
| 2022-12-31 | $0.00 10-Q · filed 2023-10-18 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-02 |
| 2021-12-31 | $0.00 10-Q · filed 2022-10-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-02 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-02 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-06 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.05M 10-K · filed 2018-03-22 |
| 2017-09-30 | $7.81M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $6.91M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $13.04M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $16.11M 10-K · filed 2017-03-21 |
| 2016-09-30 | $19.34M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $16.99M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $6.22M 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |